💉 Microfluidic In-Vitro mRNA-LNP Formulation

Automated mRNA-LNP Vaccine & Therapeutic Foundry Model

Underwrite continuous microfluidic impingement-jet mixing foundries formulating 50M doses/year of sterile mRNA encapsulated in ionizable lipid nanoparticles. Model pharma CDMO manufacturing contracts ($14.50/dose), and 20-yr IRR.

1. Capacity & Unit Economics

Annual mRNA Doses Formulated (Million Doses / Yr)

Pharma CDMO Contract Price ($ / Dose)

Sterile Lipids, Enzymes & QA OpEx ($ / Dose)

Cleanrooms, Tangential Flow & CapEx ($M)

2. Financial Returns & Yield

50M DOSES/YR MICROFLUIDIC

Annual Net EBITDA

$0 / yr

20-Yr Project IRR

0.0%

Gross Revenue

$0 / yr

Total CapEx

Annual OpEx

$0 / yr